Biennial screening produces sustained mortality reduction in CRC

There was a sustained reduction in mortality among individuals who complied with biennial fecal occult blood test screening for colorectal cancer, according to research published in Clinical Gastroenterology and Hepatology.Aasma Shaukat, MD, MPH, of the division of gastroenterology at Minneapolis Veterans Affairs Health Care system, and colleagues wrote that previous research has shown that fecal occult blood test (FOBT) screening can reduce CRC-related mortality by up to 21%.“However, none of the trials were sufficiently powered to study all-cause mortality, the effect of complianceRead More

Share on facebook
Share on twitter
Share on linkedin